Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Informed consent, risk, and blood transfusion.

J Kolins1, M D Kolins

  • 1Community Blood Bank of North County, Escondido, Calif. 92025.

The Journal of Thoracic and Cardiovascular Surgery
|July 1, 1990
PubMed
Summary

Informed consent for blood transfusions is essential due to known risks. Patients should understand options like homologous, autologous, and directed donations to assess transfusion risks, including infectious diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lawmaking: how to be heard in Lansing and Washington.

Michigan medicine·1998
Same author

MSMS task force identifies priorities with third party payers.

Michigan medicine·1994
Same author

Quality control of white cell-reduced red cells--enough is enough.

Transfusion·1993
Same author

Autologous transfusion-transmitted Yersinia enterocolitica.

JAMA·1992
Same author

Creating a uniform donor medical history questionnaire.

Transfusion·1991
Same author

Reply to invited letter concerning: Informed consent for blood transfusion (J Thorac Cardiovasc Surg 1991;101:563-4)

The Journal of thoracic and cardiovascular surgery·1991

Area of Science:

  • Transfusion Medicine
  • Infectious Disease Epidemiology
  • Patient Safety

Background:

  • Informed consent is crucial for blood transfusions due to inherent risks.
  • Transfusion services must outline patient options: homologous, autologous, and directed donations.
  • Understanding transfusion risks is vital for patient safety and decision-making.

Purpose of the Study:

  • To emphasize the necessity of informed consent for blood transfusions.
  • To detail the components of informed consent, including blood donation options.
  • To explain how to calculate and communicate transfusion-associated risks to patients.

Main Methods:

  • Review of risks associated with homologous, autologous, and directed blood donations.
  • Calculation of transfusion risk based on donor numbers and prevalence of infectious agents.
  • Explanation of comparative risks, including Human Immunodeficiency Virus (HIV), Human T-cell Leukemia Virus (HTLV), and Hepatitis C.

Main Results:

  • Informed consent processes should clearly define patient choices regarding blood transfusions.
  • Transfusion risk is quantifiable using variables such as donor pool size and undetected contamination rates.
  • Patients can be informed about specific risks, including HIV, HTLV, and Hepatitis C transmission.

Conclusions:

  • Written informed consent is a mandatory component of safe blood transfusion practices.
  • Educating patients on transfusion risks empowers them to make informed decisions.
  • Risk assessment and communication are key to mitigating adverse transfusion events and ensuring patient safety.

Related Experiment Videos